Nrf2-regulated redox signaling in brain endothelial cells adapted to physiological oxygen levels: Consequences for sulforaphane mediated protection against hypoxia-reoxygenation

Abstract

Ischemic stroke is associated with a surge in reactive oxygen species generation during reperfusion. The narrow therapeutic window for the delivery of intravenous thrombolysis and endovascular thrombectomy limits therapeutic options for patients. Thus, understanding the mechanisms regulating neurovascular redox defenses are key for improved clinical translation. Our previous studies in a rodent model of ischemic stroke established that activation of Nrf2 defense enzymes by pretreatment with sulforaphane (SFN) affords protection against neurovascular and neurological deficits. We here further investigate SFN mediated protection in mouse brain microvascular endothelial cells (bEnd.3) adapted long-term (5 days) to hyperoxic (18 kPa) and normoxic (5 kPa) O 2 levels. Using an O 2 -sensitive phosphorescent nanoparticle probe, we measured an intracellular O 2 level of 3.4 ± 0.1 kPa in bEnd 3 cells cultured under 5 kPa O 2 . Induction of HO-1 and GCLM by SFN (2.5 μM) was significantly attenuated in cells adapted to 5 kPa O 2 , despite nuclear accumulation of Nrf2. To simulate ischemic stroke, bEnd.3 cells were adapted to 18 or 5 kPa O 2 and subjected to hypoxia (1 kPa O 2 , 1 h) and reoxygenation. In cells adapted to 18 kPa O 2 , reoxygenation induced free radical generation was abrogated by PEG-SOD and significantly attenuated by pretreatment with SFN (2.5 μM). Silencing Nrf2 transcription abrogated HO-1 and NQO1 induction and led to a significant increase in reoxygenation induced free radical generation. Notably, reoxygenation induced oxidative stress, assayed using the luminescence probe L-012 and fluorescence probes MitoSOX™ Red and FeRhoNox™-1, was diminished in cells cultured under 5 kPa O 2 , indicating an altered redox phenotype in brain microvascular cells adapted to physiological normoxia. As redox and other intracellular signaling pathways are critically affected by O 2 , the development of antioxidant therapies targeting the Keap1-Nrf2 defense pathway in treatment of ischemia-reperfusion injury in stroke, coronary and renal disease will require in vitro studies conducted under well-defined O 2 levels.

Melatonin Attenuates ox‐LDL‐Induced Endothelial Dysfunction by Reducing ER Stress and Inhibiting JNK/Mff Signaling

“…Endothelial dysfunction is associated with a variety of cardiovascular disorders such as ischemic heart disease, myocardial infarction, postinfarction heart remolding, diabetic cardiomyopathy, and hypertension [1][2][3]. The cardioprotective effects of several clinical drugs, including statins, aspirin, and clopidogrel, are reportedly associated with endothelial protection [4,5].…”

MicroRNA-30d-5p ameliorates lipopolysaccharide-induced acute lung injury via activating AMPKα

“…We found that miR-30d-5p agomir also reduced LPSassociated SOD and GSH depletion in mice (Figure 3(D)). NRF2 is a redox-sensitive transcription factor and functions to inhibit oxidative damage during ALI [18,36,37]. As shown in Figure 3(E,F), LPS significantly reduced NRF2 protein level in the lungs, which was preserved by miR-30d-5p agomir treatment.…”

miR‑351‑5p aggravates lipopolysaccharide‑induced acute lung injury via inhibiting AMPK

“…2B ). NRF2 functions as a redox-sensitive transcription factor and is required for the synthesis of various antioxidant enzymes to scavenge excessive free radicals ( 20 ). As presented in Fig.…”

“…Oxidative stress is a major pathogenic factor during ALI and directly induces oxidative damage to proteins, lipids and nucleic acids, which ultimately causes cellular dysfunction and even cell death ( 4 , 7 ). NRF2 functions as a signaling hub in the regulation of redox homeostasis and is essential for the transcription of multiple antioxidant enzymes ( 20 ). Upon LPS stimulation, the NRF2 protein levels are reduced, and the expression of downstream antioxidant enzymes is suppressed, resulting in a deficiency in scavenging excessive free radicals.…”

“…AMPK also suppressed NLRP3 inflammasome activation and alleviated lipopolysaccharide (LPS)-induced ALI in mice (7,19). Nuclear factor erythroid-2 related factor 2 (NRF2) functions as a redox-sensitive transcription factor and is required for the synthesis of various antioxidant enzymes, including superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (gPx) (20)(21)(22). AMPK works upstream of NRF2, and AMPK-mediated NRF2 activation protects against the development of LPS-induced ALI (7,23,24).…”